How it works

A controlled compliance process with defined evidence gates.

Products do not proceed to notification merely because documents have been supplied. The evidence must be technically coherent and sufficient for the intended market placement.

1. Scope and product classification

We confirm the intended market, product function, presentation, user group, claims and whether the product falls within the cosmetic products framework.

2. Documentation intake

The manufacturer or brand provides the quantitative formulation, ingredient documentation, specifications, manufacturing information, test data, packaging evidence and draft label.

3. Gap analysis

We identify missing, contradictory or insufficient evidence. Critical gaps are resolved before the safety report or notification progresses.

4. Safety assessment and CPSR

The technical assessment is prepared and reviewed by the safety assessor. Any resulting conditions of safe use, warnings or limitations are carried into the label and PIF.

5. PIF and label finalisation

The PIF is assembled and the commercial artwork is checked against the assessed product and mandatory UK particulars.

6. Responsible Person mandate and SCPN

Following approval, the written RP mandate is activated and the product is notified through SCPN before Great Britain market placement.

7. Ongoing maintenance

Changes to formula, suppliers, packaging, claims, artwork or safety evidence must be assessed. Post-market information is monitored and the regulatory file remains available to authorities.